Collegium Pharmaceutical Announces Executive Changes
Ticker: COLL · Form: 8-K · Filed: 2026-04-07T16:01:23-04:00
Sentiment: neutral
Topics: executive-changes, board-of-directors, officer-departure
TL;DR
Collegium Pharma shakes up leadership, new directors in, some officers out.
AI Summary
Collegium Pharmaceutical, Inc. announced on April 2, 2026, a change in its executive team. Specifically, the company reported the departure of certain officers and the election of new directors, as detailed in Item 5.02 of their 8-K filing.
Why It Matters
Changes in key executive and director positions can signal shifts in company strategy, operational focus, or financial direction.
Risk Assessment
Risk Level: medium — Executive and director changes can introduce uncertainty regarding future company strategy and performance.
Key Players & Entities
- Collegium Pharmaceutical, Inc. (company) — Filer of the 8-K report
- 0001267565 (company) — CIK number for Collegium Pharmaceutical, Inc.
- April 2, 2026 (date) — Period of report for the 8-K filing
- April 7, 2026 (date) — Filing date of the 8-K report
- Item 5.02 (document_section) — Section of the 8-K detailing changes in directors or officers
FAQ
What specific roles have been affected by the executive changes at Collegium Pharmaceutical?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' under Item 5.02, but does not specify the exact roles in the provided text.
When was the period of report for this 8-K filing?
The period of report for this 8-K filing was April 2, 2026.
What is the CIK number for Collegium Pharmaceutical, Inc.?
The CIK number for Collegium Pharmaceutical, Inc. is 0001267565.
What is the primary business of Collegium Pharmaceutical, Inc. according to the filing?
According to the filing, Collegium Pharmaceutical, Inc. is in the Pharmaceutical Preparations industry (SIC code 2834).
On what date was this 8-K filing accepted by the SEC?
This 8-K filing was accepted by the SEC on April 7, 2026.
From the Filing
EDGAR Filing Documents for 0001628280-26-024061 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001628280-26-024061 Filing Date 2026-04-07 Accepted 2026-04-07 16:01:23 Documents 11 Period of Report 2026-04-02 Items Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Interactive Data Document Format Files Seq Description Document Type Size 1 8-K coll-20260402.htm iXBRL 8-K 23614 Complete submission text file 0001628280-26-024061.txt 141696 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT coll-20260402.xsd EX-101.SCH 1806 3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT coll-20260402_lab.xml EX-101.LAB 22548 4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT coll-20260402_pre.xml EX-101.PRE 13062 14 EXTRACTED XBRL INSTANCE DOCUMENT coll-20260402_htm.xml XML 2836 Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699 COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK : 0001267565 (see all company filings) EIN. : 000000000 | State of Incorp.: VA | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-37372 | Film No.: 26844668 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)